To test this hypothesis, we measured the mRNA levels of PLOD2 and DCLK1-L using RT-qPCR in a cDNA microarray containing paired samples from 15 ccRCC patients. The gene discussed is PLOD2; the disease is nonpapillary renal cell carcinoma.